Differences in infection prophylaxis measures between paediatric acute myeloid leukaemia study groups within the international Berlin-Frankfürt-Münster (I-BFM) study group-Reference-Cited by-同舟云学术

Differences in infection prophylaxis measures between paediatric acute myeloid leukaemia study groups within the international Berlin-Frankfürt-Münster (I-BFM) study group

Published:2018-08-03 Issue:1 Volume:183 Page:87-95
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Klein Kim¹²^ORCID,Hasle Henrik³⁴,Abrahamsson Jonas⁴⁵,De Moerloose Barbara⁶⁷,Kaspers Gertjan J. L.¹⁸⁹

Affiliation:

1. Department of Pediatric Oncology/Hematology; VU University Medical Center; Amsterdam The Netherlands

2. Department of Pediatrics; University Medical Center Utrecht/Wilhelmina Children's Hospital; Utrecht The Netherlands

3. Department of Oncology; Aarhus University Hospital Skejby; Aarhus Denmark

4. Nordic Pediatric Hematology and Oncology group; Gothenburg Sweden

5. Department of Pediatric Oncology; Queen Silvia Children's Hospital; Gothenburg Sweden

6. Department of Pediatric Hematology-Oncology and Stem Cell Transplantation; Ghent University Hospital; Ghent Belgium

7. Belgian Society of Paediatric Haematology Oncology; Utrecht The Netherlands

8. Dutch Childhood Oncology Group; Utrecht The Netherlands

9. Princess Máxima Center for Pediatric Oncology; Utrecht The Netherlands

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.15499/fullpdf

Reference37 articles.

1. Prevention of bacterial infection in pediatric oncology: what do we know, what can we learn?;Alexander;Pediatric Blood & Cancer,2012

2. Impact of granulocyte colony-stimulating factor use during induction for acute myelogenous leukemia in children: a report from the Children's Cancer Group;Alonzo;Journal of Pediatric Hematology/oncology,2002

3. Micafungin twice weekly as antifungal prophylaxis in paediatric patients at high risk for invasive fungal disease;Bochennek;Journal of Antimicrobial Chemotherapy,2015

4. Antibiotic prophylaxis with teicoplanin on alternate days reduces rate of viridans sepsis and febrile neutropenia in pediatric patients with acute myeloid leukemia;Boztug;Annals of Hematology,2017

5. Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia;Cornely;Journal of Antimicrobial Chemotherapy,2017

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antifungal Drug-Drug Interactions with Commonly Used Pharmaceutics in European Pediatric Patients with Acute Lymphoblastic Leukemia;Journal of Clinical Medicine;2023-07-12

2. Supportive care in pediatric acute myeloid leukemia:Expert-based recommendations of the NOPHO-DB-SHIP consortium;Expert Review of Anticancer Therapy;2022-10-28

3. Antibiotic prophylaxis and management of infections in pediatric hematopoietic stem cell transplantation: a survey from the Stem Cell Transplant and the Infectious Disease Working Groups of the AIEOP network;Bone Marrow Transplantation;2022-10-07

4. Invasive fungal disease in children with acute myeloid leukaemia: An Australian multicentre 10‐year review;Pediatric Blood & Cancer;2021-08-06

5. How I treat pediatric acute myeloid leukemia;Blood;2021-06-11